vs
西方石油（OXY）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
西方石油的季度营收约是瑞思迈的1.2倍（$1.7B vs $1.4B），瑞思迈净利率更高（27.6% vs 6.9%，领先20.7%），瑞思迈同比增速更快（11.0% vs -75.8%），过去两年瑞思迈的营收复合增速更高（7.8% vs -50.4%）
西方石油是一家美国能源企业，核心业务覆盖美国及中东地区的油气勘探，以及美国、加拿大、智利的石化产品制造。公司注册于特拉华州，总部位于休斯顿，2021年分别位列财富500强第183位、福布斯全球企业2000强第670位。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
OXY vs RMD — 直观对比
营收规模更大
OXY
是对方的1.2倍
$1.4B
营收增速更快
RMD
高出86.8%
-75.8%
净利率更高
RMD
高出20.7%
6.9%
两年增速更快
RMD
近两年复合增速
-50.4%
损益表 — Q4 FY2025 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.7B | $1.4B |
| 净利润 | $114.0M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | -6.5% | 34.6% |
| 净利率 | 6.9% | 27.6% |
| 营收同比 | -75.8% | 11.0% |
| 净利润同比 | 195.0% | 13.9% |
| 每股收益（稀释后） | $-0.07 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OXYRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.7B | $1.4B | ||
| Q3 25 | $6.7B | $1.3B | ||
| Q2 25 | $6.3B | $1.3B | ||
| Q1 25 | $6.9B | $1.3B | ||
| Q4 24 | $6.9B | $1.3B | ||
| Q3 24 | $7.0B | $1.2B |
净利润OXYRMD
| Q2 26 | — | $392.6M | ||
| Q1 26 | — | $398.7M | ||
| Q4 25 | $114.0M | $392.6M | ||
| Q3 25 | $842.0M | $348.5M | ||
| Q2 25 | $468.0M | $379.7M | ||
| Q1 25 | $945.0M | $365.0M | ||
| Q4 24 | $-120.0M | $344.6M | ||
| Q3 24 | $1.1B | $311.4M |
毛利率OXYRMD
| Q2 26 | — | 61.8% | ||
| Q1 26 | — | 62.2% | ||
| Q4 25 | — | 61.8% | ||
| Q3 25 | 87.8% | 61.5% | ||
| Q2 25 | 86.6% | 60.8% | ||
| Q1 25 | 88.4% | 59.3% | ||
| Q4 24 | 89.0% | 58.6% | ||
| Q3 24 | 88.5% | 58.6% |
营业利润率OXYRMD
| Q2 26 | — | 34.6% | ||
| Q1 26 | — | 34.9% | ||
| Q4 25 | -6.5% | 34.6% | ||
| Q3 25 | 17.4% | 33.4% | ||
| Q2 25 | 11.7% | 33.7% | ||
| Q1 25 | 19.3% | 33.0% | ||
| Q4 24 | -2.5% | 32.5% | ||
| Q3 24 | 22.7% | 31.6% |
净利率OXYRMD
| Q2 26 | — | 27.6% | ||
| Q1 26 | — | 27.9% | ||
| Q4 25 | 6.9% | 27.6% | ||
| Q3 25 | 12.6% | 26.1% | ||
| Q2 25 | 7.4% | 28.2% | ||
| Q1 25 | 13.7% | 28.3% | ||
| Q4 24 | -1.7% | 26.9% | ||
| Q3 24 | 16.2% | 25.4% |
每股收益（稀释后）OXYRMD
| Q2 26 | — | $2.68 | ||
| Q1 26 | — | $2.74 | ||
| Q4 25 | $-0.07 | $2.68 | ||
| Q3 25 | $0.65 | $2.37 | ||
| Q2 25 | $0.26 | $2.58 | ||
| Q1 25 | $0.77 | $2.48 | ||
| Q4 24 | $-0.32 | $2.34 | ||
| Q3 24 | $0.98 | $2.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.0B | $1.4B |
| 总债务越低越好 | $20.6B | $663.8M |
| 股东权益账面价值 | $36.0B | $6.3B |
| 总资产 | $84.2B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.57× | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资OXYRMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | — | $1.7B | ||
| Q4 25 | $2.0B | $1.4B | ||
| Q3 25 | $2.2B | $1.4B | ||
| Q2 25 | $2.3B | $1.2B | ||
| Q1 25 | $2.6B | $932.7M | ||
| Q4 24 | $2.1B | $521.9M | ||
| Q3 24 | $1.8B | $426.4M |
总债务OXYRMD
| Q2 26 | — | $663.8M | ||
| Q1 26 | — | $664.1M | ||
| Q4 25 | $20.6B | $403.9M | ||
| Q3 25 | $20.8B | $408.7M | ||
| Q2 25 | $23.3B | $658.4M | ||
| Q1 25 | $24.0B | $663.1M | ||
| Q4 24 | $25.0B | $662.9M | ||
| Q3 24 | $25.5B | $667.6M |
股东权益OXYRMD
| Q2 26 | — | $6.3B | ||
| Q1 26 | — | $6.5B | ||
| Q4 25 | $36.0B | $6.3B | ||
| Q3 25 | $36.3B | $6.1B | ||
| Q2 25 | $35.7B | $6.0B | ||
| Q1 25 | $34.7B | $5.5B | ||
| Q4 24 | $34.2B | $5.3B | ||
| Q3 24 | $34.7B | $5.2B |
总资产OXYRMD
| Q2 26 | — | $8.5B | ||
| Q1 26 | — | $8.8B | ||
| Q4 25 | $84.2B | $8.5B | ||
| Q3 25 | $83.5B | $8.3B | ||
| Q2 25 | $84.4B | $8.2B | ||
| Q1 25 | $85.0B | $7.6B | ||
| Q4 24 | $85.4B | $7.1B | ||
| Q3 24 | $85.8B | $7.2B |
负债/权益比OXYRMD
| Q2 26 | — | 0.11× | ||
| Q1 26 | — | 0.10× | ||
| Q4 25 | 0.57× | 0.06× | ||
| Q3 25 | 0.57× | 0.07× | ||
| Q2 25 | 0.65× | 0.11× | ||
| Q1 25 | 0.69× | 0.12× | ||
| Q4 24 | 0.73× | 0.13× | ||
| Q3 24 | 0.73× | 0.13× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.6B | — |
| 自由现金流经营现金流 - 资本支出 | $1.9B | — |
| 自由现金流率自由现金流/营收 | 113.4% | — |
| 资本支出强度资本支出/营收 | 45.4% | — |
| 现金转化率经营现金流/净利润 | 23.11× | — |
| 过去12个月自由现金流最近4个季度 | $4.1B | — |
8季度趋势，按日历期对齐
经营现金流OXYRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $2.6B | $339.7M | ||
| Q3 25 | $2.8B | $457.3M | ||
| Q2 25 | $3.0B | $538.8M | ||
| Q1 25 | $2.1B | $578.7M | ||
| Q4 24 | $3.4B | $308.6M | ||
| Q3 24 | $3.7B | $325.5M |
自由现金流OXYRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $1.9B | $311.2M | ||
| Q3 25 | $1.0B | $414.4M | ||
| Q2 25 | $962.0M | $508.2M | ||
| Q1 25 | $240.0M | $557.9M | ||
| Q4 24 | $1.6B | $288.0M | ||
| Q3 24 | $2.0B | $307.7M |
自由现金流率OXYRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 113.4% | 21.9% | ||
| Q3 25 | 15.3% | 31.0% | ||
| Q2 25 | 15.2% | 37.7% | ||
| Q1 25 | 3.5% | 43.2% | ||
| Q4 24 | 23.0% | 22.5% | ||
| Q3 24 | 28.5% | 25.1% |
资本支出强度OXYRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 45.4% | 2.0% | ||
| Q3 25 | 26.5% | 3.2% | ||
| Q2 25 | 31.6% | 2.3% | ||
| Q1 25 | 27.6% | 1.6% | ||
| Q4 24 | 26.0% | 1.6% | ||
| Q3 24 | 24.0% | 1.5% |
现金转化率OXYRMD
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 23.11× | 0.87× | ||
| Q3 25 | 3.31× | 1.31× | ||
| Q2 25 | 6.32× | 1.42× | ||
| Q1 25 | 2.27× | 1.59× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | 3.23× | 1.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
